Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on AQ 10. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105693530A reveals a low-energy chlorobenzene process for high-purity anthraquinone derivatives, offering substantial cost reduction and supply chain reliability.
Advanced chiral induction process for bedaquiline intermediates. Enhances yield and purity for reliable pharmaceutical intermediates supplier partnerships.
Patent CN108822170B reveals novel anthraquinone imidazole riboside analogues with improved solubility and anticancer activity, offering scalable synthetic routes for pharmaceutical intermediates.
Patent CN106316818B reveals metal-free synthesis for dimerization naphthaquinone derivatives ensuring high purity and supply chain stability for global pharmaceutical intermediates.
Novel Grignard-based route for Bedaquiline raceme offers high yield and mild conditions, ensuring reliable pharmaceutical intermediates supplier capabilities and cost reduction in API manufacturing.
Patent CN107857727A details a novel Lewis acid method for Bedaquiline, offering higher yields and safer supply chains for global pharmaceutical manufacturers.
Patent CN102119165A introduces stable chiral iridium catalysts for asymmetric transfer hydrogenation in water, offering safer and greener pharmaceutical intermediate manufacturing.
Novel silver nitrate catalyzed route offers higher yield and purity for Buparvaquone manufacturing ensuring supply chain stability and cost efficiency.
Novel silver nitrate catalyzed route enhances purity and yield for veterinary drug manufacturing supply chain stability and cost efficiency.
Patent CN105085395A details a novel bedaquiline preparation method improving yield and purity. Offers cost reduction in pharmaceutical manufacturing and scalable supply chain solutions.
Advanced synthesis of clopidogrel metabolite derivatives via stereoselective routes ensuring high purity and supply stability for global pharma partners.
Novel patent CN105085395B improves bedaquiline intermediate yield and purity significantly reducing manufacturing costs and enhancing supply chain reliability for global pharmaceutical partners.
Patent CN104892426A reveals ionic liquid catalyst for 1-nitroanthraquinone. Enhances purity and reduces waste for dye intermediate supply chains.
Discover how new buparvaquone synthesis achieves 60%+ yield and 99.5% purity without silver catalysts. Reduce costs and supply chain risks for bovine Taylor disease treatment.
Discover a cost-effective buparvaquone synthesis method with 68% yield and 99.9% purity. Avoid silver nitrate, reduce wastewater, and ensure supply chain stability for bovine disease treatment.